Strategy

Job&Talent: Hacking global expansion through M&A

Feature

Trends

AI Stack

The strategy behind the SoftBank Vision Fund

Video

Aaron Tan: How AI is driving used car sales in Asia Pacific

Data

CTO Survey: AI budgets surge

Data Analysis

Investing in biotechnology in 2025

Podcast

CHRO Survey: Hybrid work statistics say it’s here to stay, and employees are in the driver’s seat

Wes Schroll: From startup to category leader in a crowded market

Inside the SoftBank Vision Fund portfolio ecosystem

Gary Beasley: Finding opportunity in a cooling market

Venkat Sathyamurthy: A mantra for AI success

Lenskart: A vision for e-commerce success

A vision for e-commerce success

Scaling across borders

Peter Chapman: Quantum computing’s coming of age

Jack Kokko: Creating a copilot for market intelligence teams

Deidre Paknad: Redefining success metrics

CTO Survey: Generative AI is unlocking ROI in software development

Brand new: How a new identity became a unifying force for LTK

Ensuring human values are central to AI-driven progress

Nancy Stagliano: Bringing AI to life

Thirteen countries, one culture

Apollo: Seeding a revolution in Kenyan farming

Seeding a revolution in Kenyan farming

CFO Survey: AI takes center stage as economic woes recede

Generative AI takes center stage as economic woes begin to recede

Avi Meir: Why a bet on the power of human connection was key to success

Paper’s fast learning curve

CHRO Survey: Grappling with changing employee expectations

CHRO Survey: Cultures strengthen as flexible work models evolve

Leveling the financial playing field

Navigating toward growth

CFO Survey: Navigating toward growth

CEO Survey highlights: Entering 2025 with optimism and caution

2022 Milken MEA Summit: Tech Investing Panel

CEOs brace for a new wave of challenges in 2023

CHRO Survey: Despite layoffs, talent is still king

Despite layoffs, talent is still king

Clearing the path for AI adoption

Roundup

CEO Survey: As economic outlook brightens, global uncertainty casts a shadow

Efficient marketing that moves the needle

IPO Readiness: Lessons from the field

IPO readiness: Lessons from the field

CEO Insights: Thriving in the world of hybrid work

Building high-performing teams in the age of AI

Starting at discovery

Global expansion: How top companies reach beyond their borders

Hugo de Wit: Building futuristic tools to deepen cellular understanding

Turning IoT’s promise into reality

CEO Survey: Diving into AI despite an uncertain regulatory environment

Seizing the generative AI moment

Be humble and keep learning

Cloudbeds: The art of calculated risk

The art of calculated risk

Jason Warner: A bold vision for automating software on the path to AGI

Job van der Voort: The future of work is remote

Eoin Hinchy: Eliminating “muck work” through workflow automation

Making responsible and ethical AI a priority

How to invest in today’s economy

Scaling startups in enterprise, AI & tech

A new C-suite mandate: Maximizing the AI opportunity

How the C-suite is tackling a new mandate: Making the most of AI opportunities

The power of getting it wrong

CFO Survey: Capitalizing on a brighter economic outlook

CTO Survey: Targeting AI, CTOs pursue different approaches

COVID-19’s impact on technology

Remaking the last mile of e-commerce

SambaNova: Dancing with AI

CHRO Survey: Hiring is back on the front burner — selectively

Competing at the speed of AI

Doubling down on marketing in an uncertain environment

Mapbox: The fastest route to success

Leading a high-growth company through an economic downturn

CEO Survey: Prepping for a rebound

Prepping for a rebound

CFO Survey: How CFOs are navigating a changing market

Ken Drazan: Building an LLM that speaks the language of the immune system

Navigating the AI ecosystem

Data and machine learning are creating a golden age of drug discovery

CHRO Survey: AI is transforming how people leaders build winning teams

Marcelo Bigal: Always putting patients first

Variant Bio: Genomic discovery on the road less traveled

Variant Bio: Charting a New Path in Genomic Drug Discovery

Explore exclusive survey data

CHRO - Q1 2025

Terms

Privacy

Regulatory

Portfolio

Team

Insights

Work With Us

Portfolio Careers

Sustainability

Presentations

Company

Contact

We use necessary cookies to make our site work. We would also like to set optional analytics cookies to help us improve our site by anonymously collecting and reporting information on how you use it. For more information on how these cookies work, please see our <a target="_blank" href="https://visionfund.com/terms#1&amp;cookie-policy">Cookie policy</a>.

Scaling startups in enterprise, AI & tech

Nahoko Hoshino discusses investing in European enterprise startups, highlighting the advantages of building businesses in Europe.

Variant Bio: Genomic discovery on the road less traveled

Explore exclusive survey data

The strength of 450+ leading tech companies—direct to your inbox